Position in AVXL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$378,994
-$17,573 QoQ
Shares Held
146,330
+13.3% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 179 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $901,256,539 across 108 Biotechnology names. AVXL ranks #85 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in AVXL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $378,994 | 146,330 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $396,567 | 129,175 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $312,119 | 87,674 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $533,492 | 59,943 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $457,072 | 49,574 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $454,757 | 53,002 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $634,368 | 59,066 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $217,515 | 38,295 | Shares | Sole | 2024-11-07 | |
| No filing history on record for this holder in this stock. | ||||||